Human Reproduction, Vol. 15, No. 3, 646-649,
March 2000
© 2000 European Society of Human Reproduction and Embryology
Would women trust their partners to use a male pill?
1 Contraceptive Development Network at Department of Obstetrics and Gynaecology, Centre for Reproductive Biology, The University of Edinburgh, 37 Chalmers Street, Edinburgh EH3 9EW, UK, 2 Department of Obstetrics & Gynaecology, University of Cape Town, Medical School, Anzio Road, Observatory, South Africa 7925, 3 Shanghai Institute of Family Planning and Technical Instruction, International Peace Maternity & Child Health Hospital, China Welfare Institute, 145 Guangyuan Road, Shanghai 200030, People's Republic of China and 4 Department of Obstetrics & Gynaecology, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong
Despite a renewed interest in the development of hormonal contraceptives for men, many discussions about the potential acceptability of a `male pill' end by speculating whether women would trust their partners to use the method reliably. To determine the views of women, we undertook a survey of 1894 women attending family planning clinics in Scotland (450), China (900) and South Africa (544). In all centres over 65% of women thought that the responsibility for contraception falls too much on women. More than 90% in South Africa and Scotland thought that a `male pill' was a good idea, with Chinese women (71% in Hong Kong and 87% in Shanghai) only slightly less positive. Only 13% of the total sample did not think that hormonal male contraception was a good idea and only 36 women (2% of the total) said that they would not trust their partner to use it. 78% of Scottish women, 71% of Shanghai women, and 78% of white women and 40% of black and coloured women in Cape Town thought that they would use the method. This survey should dispel the myth that women would not trust their partners to use a `male pill' reliably and illustrates the potential market for the method.
Key words: hormonal contraception/male/women's attitudes
5 To whom correspondence should be addressed at: Family Planning & Well Woman Services, Edinburgh Primary Care NHS Trust, 18 Dean Terrace, Edinburgh EH4 1NL, UK
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. T. Page, J. K. Amory, and W. J. Bremner Advances in Male Contraception Endocr. Rev., June 1, 2008; 29(4): 465 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.C. Meriggiola, S. Cerpolini, W.J. Bremner, M.T. Mbizvo, K.M. Vogelsong, G. Martorana, and G. Pelusi Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men Hum. Reprod., August 1, 2006; 21(8): 2033 - 2040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Matthiesson and R. I. McLachlan Male hormonal contraception: concept proven, product in sight? Hum. Reprod. Update, July 1, 2006; 12(4): 463 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Marcell, K. Plowden, and S. M. Bowman Exploring older adolescents' and young adults' attitudes regarding male hormonal contraception: applications for clinical practice Hum. Reprod., November 1, 2005; 20(11): 3078 - 3084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Heinemann, F. Saad, M. Wiesemes, and L. A. J. Heinemann Expectations Toward a Novel Male Fertility Control Method and Potential User Types: Results of a Multinational Survey J Androl, March 1, 2005; 26(2): 155 - 162. [Full Text] [PDF]
|
|
|
|
|
|
K. Heinemann, F. Saad, M. Wiesemes, S. White, and L. Heinemann Attitudes toward male fertility control: results of a multinational survey on four continents Hum. Reprod., February 1, 2005; 20(2): 549 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Turner, A. J. Conway, M. Jimenez, P. Y. Liu, E. Forbes, R. I. McLachlan, and D. J. Handelsman Contraceptive Efficacy of a Depot Progestin and Androgen Combination in Men J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4659 - 4667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Meriggiola, T. M.M. Farley, and M. T. Mbizvo A Review of Androgen-Progestin Regimens for Male Contraception J Androl, July 1, 2003; 24(4): 466 - 483. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Handelsman Hormonal Male Contraception--Lessons from the East When the Western Market Fails J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 559 - 561. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Anderson and D. T. Baird Male Contraception Endocr. Rev., December 1, 2002; 23(6): 735 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.A. Anderson, Z.M. van der Spuy, O.A. Dada, S.K. Tregoning, P.M. Zinn, O.A. Adeniji, T.A. Fakoya, K.B. Smith, and D.T. Baird Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone Hum. Reprod., November 1, 2002; 17(11): 2869 - 2877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, and R.A. Anderson Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men Hum. Reprod., June 1, 2002; 17(6): 1490 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.W. Martin, R.A. Anderson, L. Cheng, P.C. Ho, Z. van derSpuy, K.B. Smith, A.F. Glasier, D. Everington, and D.T. Baird Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations Hum. Reprod., March 1, 2000; 15(3): 637 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kamischke, S. Venherm, D. Plöger, S. von Eckardstein, and E. Nieschlag Intramuscular Testosterone Undecanoate and Norethisterone Enanthate in a Clinical Trial for Male Contraception J. Clin. Endocrinol. Metab., January 1, 2000; 86(1): 303 - 309. [Abstract] [Full Text]
|
|